Previous studies have reported that inhibition of CAXII can promote apoptosis, therefore suppress cancer malignancy and proliferation via different pathways in breast cancer cells and T-cell lymphoma cells10,35,36, which is in line with the findings in our study. This evidence concerns the gene CA12 and T-cell non-Hodgkin lymphoma.